SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Cost Per DALY Averted Thresholds for Low- and Middle-Income Countries: Evidence From Cross Country Data
13 references·0 citing·48 second hop
Cost Per DALY Averted Thresholds for Low- and Middle-Income Countries: Evidence From Cross Country Data (2017)Cost Per DALY Averted Thresholds for Low-…Methods for the estimation of the National Institute for Health and Care Excellence cost-effectiveness threshold (2015)Methods for the estimation of…Updating Cost-Effectiveness — The Curious Resilience of the $50,000-per-QALY Threshold (2014)Updating Cost-Effectiveness —…CAUSES FOR CONCERN: IS NICE FAILING TO UPHOLD ITS RESPONSIBILITIES TO ALL NHS PATIENTS? (2014)CAUSES FOR CONCERN: IS NICE F…Are Current Cost-Effectiveness Thresholds for Low- and Middle-Income Countries Useful? Examples from the World of Vaccines (2014)Are Current Cost-Effectivenes…Common values in assessing health outcomes from disease and injury: disability weights measurement study for the Global Burden of Disease Study 2010 (2012)Common values in assessing he…The Income Elasticity of the Value per Statistical Life: Transferring Estimates between High and Low Income Populations (2011)The Income Elasticity of the …On the simultaneity problem in the aid and growth debate (2011)On the simultaneity problem i…Evidence-Based Decision-Making in Asia-Pacific with Rapidly Changing Health-Care Systems: Thailand, South Korea, and Taiwan (2009)Evidence-Based Decision-Makin…Assessing cost-effectiveness in healthcare: history of the $50,000 per QALY threshold (2008)Assessing cost-effectiveness …National Institute for Clinical Excellence and its value judgments (2004)National Institute for Clinic…Does NICE have a cost‐effectiveness threshold and what other factors influence its decisions? A binary choice analysis (2004)Does NICE have a cost‐effecti…Mathematical programming for the efficient allocation of health care resources (1996)Mathematical programming for …Critical ratios and efficient allocation (1973)Critical ratios and efficient…Measurement of health state utilities for economic appraisal (1986)The world health report 2001 - Mental health: new understanding, new hope (2001)The burden of disease and injury in Australia 2003 (2007)Global burden of disease attributable to mental and substance use disorders: findings from the Global Burden of Disease Study 2010 (2013)Global, regional, and national age–sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013 (2014)Global, regional, and national disability-adjusted life-years (DALYs) for 359 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017 (2018)The PHQ-9 (2001)Methods for the Economic Evaluation of Health Care Programmes (2005)A Brief Measure for Assessing Generalized Anxiety Disorder (2006)Cost–effectiveness thresholds: pros and cons (2016)The International Decision Support Initiative Reference Case for Economic Evaluation: An Aid to Thought (2016)Using health technology assessment to assess the value of new medicines: results of a systematic review and expert consultation across eight European countries (2017)A utility maximization model for evaluation of health care programs. (1972)Operations Research: Applications and Algorithms (1988)Estimating CE Ratios under Second-order Uncertainty (1997)Opportunity costs and uncertainty in the economic evaluation of health care interventions (2002)OFT, VBP: QED? (2007)The irrelevance of inference: a decision-making approach to the stochastic evaluation of health care technologies (1999)Key principles for the improved conduct of health technology assessments for resource allocation decisions (2008)International survey on willingness‐to‐pay (WTP) for one additional QALY gained: what is the threshold of cost effectiveness? (2009)Willingness to Pay for a Quality-adjusted Life Year (2000)What Does the Value of Modern Medicine Say About the $50,000 per Quality-Adjusted Life-Year Decision Rule? (2008)Country-Level Cost-Effectiveness Thresholds: Initial Estimates and the Need for Further Research (2016)Recommendations for Conduct, Methodological Practices, and Reporting of Cost-effectiveness Analyses (2016)Economics and mental health: the current scenario (2020)The problem of fair division (1948)Incremental cost-effectiveness ratios (ICERs): The silence of the lambda (2005)The Willingness to Pay for a Quality Adjusted Life Year: A Review of the Empirical Literature (2014)Estimating the Reference Incremental Cost-Effectiveness Ratio for the Australian Health System (2017)How attractive does a new technology have to be to warrant adoption and utilization? Tentative guidelines for using clinical and economic evaluations. (1992)EuroQol: the current state of play (1996)Decision Making in Health and Medicine: Integrating Evidence and Values (2001)Systematic reviews in the social sciences: a practical guide (2006)Delivering affordable cancer care in high-income countries (2011)The Value of a Statistical Life: A Critical Review of Market Estimates Throughout the World (2003)Cost-Effectiveness of Interventions to Prevent and Control Diabetes Mellitus: A Systematic Review (2010)On what basis are medical cost-effectiveness thresholds set? Clashing opinions and an absence of data: a systematic review (2018)The value of risks to life and health (1993)What determines the value of life? a meta‐analysis (2002)Valuing Mortality Risk Reductions from Environmental, Transport, and Health Policies: A Global Meta‐Analysis of Stated Preference Studies (2011)The effects of road pricing on driver behavior and air pollution (2015)Valuing Mortality Risk Reductions in Global Benefit-Cost Analysis (2019)Initial conditions and moment restrictions in dynamic panel data models (1995)Initial conditions and moment restrictions in dynamic panel data models (1998)Testing for unit roots in heterogeneous panels (2003)African leaders and the geography of China's foreign assistance (2019)Inequality of opportunity, inequality of income and economic growth (2020)Econometric Analysis of Panel Data (2021)
this work references cited by second hop

References

  • 2014Updating Cost-Effectiveness — The Curious Resilience of the $50,000-per-QALY Threshold2,303 cited
  • 2012Common values in assessing health outcomes from disease and injury: disability weights measurement study for the Global Burden of Disease Study 20101,349 cited
  • 2015Methods for the estimation of the National Institute for Health and Care Excellence cost-effectiveness threshold857 cited
  • 2004National Institute for Clinical Excellence and its value judgments767 cited
  • 2004Does NICE have a cost‐effectiveness threshold and what other factors influence its decisions? A binary choice analysis710 cited
  • 2008Assessing cost-effectiveness in healthcare: history of the $50,000 per QALY threshold637 cited
  • 2011The Income Elasticity of the Value per Statistical Life: Transferring Estimates between High and Low Income Populations316 cited
  • 1973Critical ratios and efficient allocation280 cited
  • 2011On the simultaneity problem in the aid and growth debate181 cited
  • 1996Mathematical programming for the efficient allocation of health care resources163 cited
  • 2014CAUSES FOR CONCERN: IS NICE FAILING TO UPHOLD ITS RESPONSIBILITIES TO ALL NHS PATIENTS?114 cited
  • 2014Are Current Cost-Effectiveness Thresholds for Low- and Middle-Income Countries Useful? Examples from the World of Vaccines100 cited
  • 2009Evidence-Based Decision-Making in Asia-Pacific with Rapidly Changing Health-Care Systems: Thailand, South Korea, and Taiwan

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work

47 cited

Cited by

No citing works inside the corpus for this window.